Temporal lobe epilepsy (TLE) is the most common type of pharmacoresistant focal epilepsy, for which anterior mesial temporal lobe resection (AMTLR) is a treatment option. Focal cortical dysplasia Type IIIa (FCD IIIa), a developmental lesion resulting from defects in neuronal formation and migration into the temporal pole (FCD I) combined with hippocampal sclerosis (HS), can be a neuropathological finding. In this study, the authors investigate the impact of FCD IIIa on seizure outcome in patients with TLE who underwent AMTLR.
The authors performed a retrospective analysis of all patients with TLE who underwent AMTLR at their institution between June 2011 and April 2014. Histopathological analysis was used to determine whether patients had HS together with FCD I (FCD IIIa) or HS alone. The groups were compared with regard to age, sex, years of epilepsy, and seizure outcome using the Engel classification.
A total of 51 patients with TLE underwent AMTLR at the authors’ institution. FCD IIIa was diagnosed in 13 cases. The patients experienced seizures for a mean duration of 31.1 years. The mean length of follow-up after the procedure was 18 months. All patients with FCD IIIa had a favorable seizure outcome (Engel Class I or II) compared with 71% of the patients with no pathological findings in the temporal pole (p < 0.01).
Patients with histopathologically proven FCD IIIa had a significantly better seizure outcome after AMTLR than patients with HS alone. Further effort should be made during presurgical evaluation to detect FCD IIIa so that the most suitable resection technique can be chosen and postoperative seizure outcome can be predicted for patient counseling.
INCLUDE WHEN CITING Published online July 28, 2017; DOI: 10.3171/2017.2.JNS161295.
Disclosures The authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper.
Barba C, Rheims S, Minotti L, Guénot M, Hoffmann D, Chabardès S, et al.: Temporal plus epilepsy is a major determinant of temporal lobe surgery failures. Brain 139:444–451, 2016
Blümcke I, Thom M, Aronica E, Armstrong DD, Bartolomei F, Bernasconi A, et al.: International consensus classification of hippocampal sclerosis in temporal lobe epilepsy: a Task Force report from the ILAE Commission on Diagnostic Methods. Epilepsia 54:1315–1329, 2013
Blümcke I, Thom M, Aronica E, Armstrong DD, Vinters HV, Palmini A, et al.: The clinicopathologic spectrum of focal cortical dysplasias: a consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission. Epilepsia 52:158–174, 2011
Di Gennaro G, D’Aniello A, De Risi M, Grillea G, Quarato PP, Mascia A, et al.: Temporal pole abnormalities in temporal lobe epilepsy with hippocampal sclerosis: Clinical significance and seizure outcome after surgery. Seizure 32:84–91, 2015
Donkels C, Pfeifer D, Janz P, Huber S, Nakagawa J, Prinz M, et al.: Whole transcriptome screening reveals myelination deficits in dysplastic human temporal neocortex. Cereb Cortex 27:1558–1572, 2017
Engel J Jr, McDermott MP, Wiebe S, Langfitt JT, Stern JM, Dewar S, et al.: Early surgical therapy for drug-resistant temporal lobe epilepsy: a randomized trial. JAMA 307:922–930, 2012
Engel J Jr, Van Ness PC, Rasmussen TB, Ojemann LM: Outcome with respect to epileptic seizures, in Engel J Jr (ed): Surgical Treatment of the Epilepsies, ed 2. New York: Raven Press, 1993, pp 609–621
Fabera P, Krijtova H, Tomasek M, Krysl D, Zamecnik J, Mohapl M, et al.: Familial temporal lobe epilepsy due to focal cortical dysplasia type IIIa. Seizure 31:120–123, 2015
Fauser S, Häussler U, Donkels C, Huber S, Nakagawa J, Prinz M, et al.: Disorganization of neocortical lamination in focal cortical dysplasia is brain-region dependent: evidence from layer-specific marker expression. Acta Neuropathol Commun 1:47, 2013
House PM, Brückner KE, Lohmann HH: Presurgical functional transcranial Doppler sonography (fTCD) with intravenous echo enhancing agent SonoVue enables determination of language lateralization in epilepsy patients with poor temporal bone windows. Epilepsia 52:636–639, 2011
House PM, Holst B, Lindenau M, Voges B, Kohl B, Martens T, et al.: Morphometric MRI analysis enhances visualization of cortical tubers in tuberous sclerosis. Epilepsy Res 117:29–34, 2015
House PM, Lanz M, Holst B, Martens T, Stodieck S, Huppertz HJ: Comparison of morphometric analysis based on T1- and T2-weighted MRI data for visualization of focal cortical dysplasia. Epilepsy Res 106:403–409, 2013
Hu WH, Zhang C, Zhang K, Meng FG, Chen N, Zhang JG: Selective amygdalohippocampectomy versus anterior temporal lobectomy in the management of mesial temporal lobe epilepsy: a meta-analysis of comparative studies. J Neurosurg 119:1089–1097, 2013
Huppertz HJ, Grimm C, Fauser S, Kassubek J, Mader I, Hochmuth A, et al.: Enhanced visualization of blurred gray-white matter junctions in focal cortical dysplasia by voxel-based 3D MRI analysis. Epilepsy Res 67:35–50, 2005
Johnson AM, Sugo E, Barreto D, Cunningham AM, Hiew CC, Lawson JA, et al.: Clinicopathological associations in temporal lobe epilepsy patients utilising the current ILAE focal cortical dysplasia classification. Epilepsy Res 108:1345–1351, 2014
Josephson CB, Dykeman J, Fiest KM, Liu X, Sadler RM, Jette N, et al.: Systematic review and meta-analysis of standard vs selective temporal lobe epilepsy surgery. Neurology 80:1669–1676, 2013
Kim DW, Kim S, Park SH, Chung CK, Lee SK: Comparison of MRI features and surgical outcome among the subtypes of focal cortical dysplasia. Seizure 21:789–794, 2012
Lee TM, Yip JT, Jones-Gotman M: Memory deficits after resection from left or right anterior temporal lobe in humans: a meta-analytic review. Epilepsia 43:283–291, 2002
Marucci G, Farnedi A, Giulioni M: Reelin: a possible link between hippocampal sclerosis and cortical dyslamination in the setting of FCD type IIIa. Neurol Sci 33:1479–1481, 2012
Reeves C, Tachrount M, Thomas D, Michalak Z, Liu J, Ellis M, et al.: Combined ex vivo 9.4T MRI and quantitative histopathological study in normal and pathological neocortical resections in focal epilepsy. Brain Pathol 26:319–333, 2016
Schramm J: Temporal lobe epilepsy surgery and the quest for optimal extent of resection: a review. Epilepsia 49:1296–1307, 2008
Spreafico R, Blümcke I: Focal cortical dysplasias: clinical implication of neuropathological classification systems. Acta Neuropathol 120:359–367, 2010
Tassi L, Garbelli R, Colombo N, Bramerio M, Lo Russo G, Deleo F, et al.: Type I focal cortical dysplasia: surgical outcome is related to histopathology. Epileptic Disord 12:181–191, 2010
Thom M, Eriksson S, Martinian L, Caboclo LO, McEvoy AW, Duncan JS, et al.: Temporal lobe sclerosis associated with hippocampal sclerosis in temporal lobe epilepsy: neuropathological features. J Neuropathol Exp Neurol 68:928–938, 2009
Wang ZI, Alexopoulos AV, Jones SE, Najm IM, Ristic A, Wong C, et al.: Linking MRI postprocessing with magnetic source imaging in MRI-negative epilepsy. Ann Neurol 75:759–770, 2014
West S, Nolan SJ, Cotton J, Gandhi S, Weston J, Sudan A, et al.: Surgery for epilepsy. Cochrane Database Syst Rev (7):CD010541, 2015
| All Time | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 602 | 112 | 32 |
| Full Text Views | 1266 | 102 | 0 |
| PDF Downloads | 1033 | 100 | 0 |
| EPUB Downloads | 0 | 0 | 0 |
